VH3810109
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for VH3810109, covering 2024-09-19 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV [Phase 1]